Table 4 After given statins, the change of serum lipid and kidney damage indicators and serum ANGPTL3 (x‵ ± s)
From: Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria
Group | Untreated group (n = 25) | Treatment group (n = 46) | t | p |
|---|---|---|---|---|
BMI | 24.65 ± 3.97 | 25.04 ± 3.91 | 0.395 | 0.694 |
TC (mmol/L) | 5.93 ± 2.56 | 6.34 ± 1.70 | 0.811 | 0.420 |
TG (mmol/L) | 3.61 ± 1.83 | 4.63 ± 3.99 | 1.474 | 0.145 |
HDL (mmol/L) | 1.34 ± 0.64 | 1.27 ± 0.44 | −0.565 | 0.574 |
LDL (mmol/L) | 3.99 ± 2.23 | 3.89 ± 1.38 | − 0.218 | 0.828 |
24hUPro (g/d) | 2.13 ± 4.28 | 1.06 ± 1.67 | −1.207 | 0.237 |
Serum ANGPTL3 (ng/ml) | 105.4 ± 88.51 | 78.33 ± 69.37 | −1.423 | 0.159 |